Share

Financial news - May 2023 - news published 76.217 - readings 1.013.617

Select company / Select period
Achilles Therapeutics plc

Achilles Therapeutics plc

Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

- Phase I/IIa clinical trials in NSCLC and melanoma progressing with additional clinical and translational science data expected in the fourth quarter of 2023 - - Strong cash position of $158.5 million supports operations into mid-2025 - LONDON, May 10, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-p ...

Continue reading
10.05.2023
The Middleby Corporation

The Middleby Corporation

The Middleby Corporation Reports Record First Quarter Results - Form 8-K

The Middleby Corporation Reports Record First Quarter Results Revenue of $1,007 million, a 1% increase year over year Diluted Earnings per share of $1.82 and adjusted net earnings per share of $2.19, an increase of 3% year over year Adjusted EBITDA of $210 million, a 6% increase year over year Profitability grew to an organic adjusted EBITDA margin of 21.1% compared to 19.8% i ...

Continue reading
10.05.2023
Beam Therapeutics Inc.

Beam Therapeutics Inc.

Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results - Form 8-K

Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results Focused on Executing Three Strategic Pillars - Hematology, Immunology/Oncology and Genetic Diseases - Potential for Long-Term Pipeline Growth and Sustained Impact on Patient Lives Multiple Sites Activated and Additional Patients Enrolled in BEACON Clinical Trial of BEAM-101 for Patients with Si ...

Continue reading
10.05.2023
PFG - Performance Food Group Company

PFG - Performance Food Group Company

Performance Food Group Company Reports Third-Quarter and First-Nine Months Fiscal 2023 Results - Form 8-K

Performance Food Group Company Reports Third-Quarter and First-Nine Months Fiscal 2023 Results Total and Independent Organic Case Growth Accelerates, Double Digit Profit Growth and Strong Cash Flow; Raises and Tightens Fiscal 2023 Adjusted EBITDA Outlook Range Third-Quarter Fiscal 2023 Highlights • Total case volume grew 3% • Net sales increased 5% to $13.8 billion • Gro ...

Continue reading
10.05.2023
Endeavour Silver Corporation

Endeavour Silver Corporation

Endeavour Silver Announces Q1 2023 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today

VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE: EXK; TSX: EDR) is pleased to announce its financial and operating results for the three months ended March 31, 2023. All dollar amounts are in US dollars (US$). "We are pleased to report a solid start this year with consolidated pr ...

Continue reading
10.05.2023